SG
Sonal Gautam Shah
About Sonal Gautam Shah
Data last updated:
Sonal Gautam Shah is a Director at G.C. Chemie Pharmie Limited (since 1995), Director at Vitamystic Healthcare Private Limited (since 2022) and Director at Eagle Chemical Works Private Limited (since 2026), and holds 3 more current directorships. The companies operate in Pharma and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹561 Cr; the largest is G.C. Chemie Pharmie Limited at ₹557 Cr (FY 2025). Earlier, Sonal Gautam Shah was a Director at Manmill Sciences Private Limited (2008–2025) and Director at Novo Excipients Private Limited (2011–2024) and 2 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 G.C. Chemie Pharmie Limited U51900MH1995PLC088175 | Director | 08 May 1995 | 1995 | ₹557 Cr (FY 2025) | Active |
 Vitamystic Healthcare Private Limited U24290MH2022PTC375036 | Director | 18 Jan 2022 | 2022 | ₹4.62 Cr (FY 2025) | Active |
| Eagle Chemical Works Private Limited U21001GJ2026PTC179760 | Director | 27 Jun 2026 | 2026 | Active | |
| Metaverse Pharmaceuticals Private Limited U24230MH2022PTC382991 | Director | 20 May 2022 | 2022 | Active | |
| Pravi Lifesciences Llp AAR-1980 | Partner | 02 Dec 2019 | 2019 | Under Process Of Striking Off | |
| Cira Herbals Llp AAO-9701 | Designated Partner | 20 Apr 2019 | 2019 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Manmill Sciences Private Limited U74110MH2008PTC187588 | Director | 16 Oct 2008 | 2008 | ₹100 Lakh (FY 2025) | Active |
 Novo Excipients Private Limited U24230MH2003PTC142463 | Director | 26 Aug 2011 | 2003 | ₹104 Cr (FY 2025) | Active |
 Nivaara Chemicals Private Limited U24297MH2009PTC196606 | Director | 22 Oct 2009 | 2009 | ₹8.59 Cr (FY 2025) | Active |
| Man-Mill Chemicals P Ltd U24110MH1993PTC075298 | Director | 25 Nov 1993 | 1993 | ₹11.57 Cr (FY 2023) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sonal Gautam Shah
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dhrumill Gautam Shah | 09569026 | G.C. Chemie Pharmie Limited | Director |
| Gautam Chandrakumar Shah | 00271794 | G.C. Chemie Pharmie Limited , Vitamystic Healthcare Private Limited and 2 more | Managing Director |
| Jaydeep Vinod Mehta | 00252474 | G.C. Chemie Pharmie Limited | Director |
| Manitt Gautam Shah | 09564268 | G.C. Chemie Pharmie Limited | Director |
| Umesh Ravikant Mehta | 00196468 | G.C. Chemie Pharmie Limited | Director |
| Anjana Murlimanohar Modani | 00796085 | Pravi Lifesciences Llp | Designated Partner |
| Dev Sarop Chand | 08602510 | Pravi Lifesciences Llp | Designated Partner |
| Ram Gopal Mandowara | 07561891 | Pravi Lifesciences Llp | Partner |
| Ritendre Singh Matharu | 06780472 | Cira Herbals Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sonal Gautam Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sonal Gautam Shah
Sonal Gautam Shah currently holds 6 directorships: G.C. Chemie Pharmie Limited (Director, since 08 May 1995, revenue ₹557 Cr (FY 2025)); Vitamystic Healthcare Private Limited (Director, since 18 Jan 2022, revenue ₹4.62 Cr (FY 2025)); Eagle Chemical Works Private Limited (Director, since 27 Jun 2026); Metaverse Pharmaceuticals Private Limited (Director, since 20 May 2022); Pravi Lifesciences Llp (Partner, since 02 Dec 2019); and 1 more.
Sonal Gautam Shah was first appointed on 25 Nov 1993 as Director at Man-Mill Chemicals P Ltd. The most recent appointment on record is 27 Jun 2026 at Eagle Chemical Works Private Limited.
The 2 current companies of Sonal Gautam Shah that report revenue have a combined latest revenue of ₹561 Cr: G.C. Chemie Pharmie Limited ₹557 Cr (FY 2025); Vitamystic Healthcare Private Limited ₹4.62 Cr (FY 2025).
Sonal Gautam Shah held 4 earlier board appointments: Manmill Sciences Private Limited (Director, 16 Oct 2008 to 06 Jan 2025); Novo Excipients Private Limited (Director, 26 Aug 2011 to 01 Dec 2024); Nivaara Chemicals Private Limited (Director, 22 Oct 2009 to 30 May 2019); Man-Mill Chemicals P Ltd (Director, from 25 Nov 1993).
The current boards of Sonal Gautam Shah's companies include Dhrumill Gautam Shah (G.C. Chemie Pharmie Limited), Gautam Chandrakumar Shah (G.C. Chemie Pharmie Limited), Jaydeep Vinod Mehta (G.C. Chemie Pharmie Limited), Manitt Gautam Shah (G.C. Chemie Pharmie Limited), Umesh Ravikant Mehta (G.C. Chemie Pharmie Limited), Anjana Murlimanohar Modani (Pravi Lifesciences Llp), among others.